Cargando…
Feasibility of Fecal MicroRNAs as Novel Biomarkers for Pancreatic Cancer
INTRODUCTION: Pancreatic cancer (PCA) is an aggressive tumor that associates with high mortality rates. Majority of PCA patients are diagnosed usually at late tumor stages when the therapeutic options are limited. MicroRNAs (miRNA) are involved in tumor development and are commonly dysregulated in P...
Autores principales: | Link, Alexander, Becker, Verena, Goel, Ajay, Wex, Thomas, Malfertheiner, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414456/ https://www.ncbi.nlm.nih.gov/pubmed/22905187 http://dx.doi.org/10.1371/journal.pone.0042933 |
Ejemplares similares
-
Differential expression of microRNAs in preneoplastic gastric mucosa
por: Link, Alexander, et al.
Publicado: (2015) -
Inflammatory microRNAs in gastric mucosa are modulated by Helicobacter pylori infection and proton-pump inhibitors but not by aspirin or NSAIDs
por: Vasapolli, Riccardo, et al.
Publicado: (2021) -
Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer
por: Juzėnas, Simonas, et al.
Publicado: (2015) -
Fecal microRNAs, Fecal microRNA Panels, or Combinations of Fecal microRNAs with Fecal Hemoglobin for Early Detection of Colorectal Cancer and Its Precursors: A Systematic Review
por: Zhao, Zitong, et al.
Publicado: (2021) -
Fecal MicroRNAs Show Promise as Noninvasive Crohn’s Disease Biomarkers
por: Wohnhaas, Christian T, et al.
Publicado: (2020)